Bacteriostatic water is sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative, supplied in a multiple-dose container so that repeated withdrawals can be made from the same vial. In research peptide work it is the standard diluent for reconstituting a lyophilised vial that will be sampled more than once. This guide explains how it differs from sterile water and saline, where the 28-day convention comes from, and how to choose a diluent for laboratory solution preparation.
Key takeaways
- Bacteriostatic water for injection USP contains 0.9% (9 mg/mL) benzyl alcohol as a preservative; the pH is 5.7 with a specification range of 4.5 to 7.0.
- Benzyl alcohol is bacteriostatic, not bactericidal. It suppresses the growth of organisms introduced during withdrawal; it does not sterilise a contaminated solution.
- The widely used 28-day discard convention for an opened multi-dose vial comes from injection-safety guidance, not from peptide chemistry.
- Sterile water for injection has no preservative and is intended for single use; it is the right choice when a vial will be reconstituted and consumed in one session.
- 0.9% sodium chloride is isotonic and useful for assay work, but it is unpreserved and can promote aggregation for some sequences at higher ionic strength.
- Dilute acetic acid is a specialist option for poorly soluble basic peptides, used sparingly and then diluted out.
- Diluent choice does not extend the chemical shelf life of a peptide in solution. Only the dry lyophilised state does that.
What is bacteriostatic water?
Bacteriostatic water for injection USP is water for injection to which benzyl alcohol has been added as a bacteriostatic preservative. The United States Pharmacopeia monograph product is described as containing “0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol added as a bacteriostatic preservative”, with a pH of 5.7 and a specification range of 4.5 to 7.0.1 The 0.9% presentation is by far the most common in research supply.
The defining feature is not the water — it is the container concept. The label describes a “multiple-dose container from which repeated withdrawals may be made to dilute or dissolve drugs for injection”.1 That is the entire point. A preserved diluent is what makes it defensible to enter the same reconstituted vial on Monday and again on Thursday.
In a research setting the parallel is exact. A 5 mg lyophilised peptide vial that will be sampled twenty times over several weeks is a multi-entry container, and each entry carries a small risk of introducing organisms from the septum surface, the needle, or the air displaced into the vial. A bacteriostatic diluent suppresses whatever gets in.
How benzyl alcohol works
Benzyl alcohol is an aromatic alcohol that partitions into microbial membranes, disrupts membrane integrity and arrests growth at the concentrations used in preserved parenterals. The key word is bacteriostatic: at 0.9% it holds a population in check rather than destroying it. A grossly contaminated solution stays contaminated.
That distinction is often lost. Bacteriostatic water does not sterilise a peptide vial, does not rescue a vial that was reconstituted with a dirty needle, and does not compensate for skipping the alcohol wipe on the septum. It buys tolerance for the small, repeated, low-level challenge that multiple entries create.
Where benzyl alcohol is not appropriate
Benzyl alcohol carries a well-documented toxicity in neonates. Gershanik and colleagues described the gasping syndrome associated with benzyl alcohol exposure in newborn infants in 1982,2 and modern labels for bacteriostatic water carry a prominent “NOT FOR USE IN NEONATES” statement, directing that preservative-free sterile water be used instead.1 This is a fact about the preservative, stated here because it explains why unpreserved presentations exist at all.
In laboratory work the practical corollaries are different but related. Benzyl alcohol is a small organic molecule that will appear in a mass spectrum, contributes UV absorbance, and is not inert in every cell-based assay. Where the downstream measurement is sensitive to the matrix, an unpreserved diluent is the better technical choice.
Compatibility with peptides
For the large majority of research peptides, 0.9% benzyl alcohol is compatible at the concentrations used for reconstitution. There is no general chemical incompatibility between benzyl alcohol and a peptide backbone. What varies is whether the slightly acidic, low-ionic-strength environment suits the particular sequence, and that is a solubility question rather than a preservative question.
Bachem’s technical guidance on peptide solubility recommends selecting a solvent from the peptide’s own charge character: basic peptides are dissolved in a small amount of an acidic solvent such as acetic acid before dilution, acidic peptides in a small amount of a basic solvent, and neutral or hydrophobic peptides in an organic solvent before dilution into aqueous medium. It also advises testing solubility on a small amount first and using brief water-bath sonication, avoiding excessive heating.3
Bacteriostatic water vs sterile water vs saline
The choice between these three comes down to one question: how many times will the vial be entered? A single-session reconstitution has no preservative requirement and is better served by the simplest possible matrix. A vial that will be sampled repeatedly over weeks needs a preserved diluent.
Sterile water for injection is unpreserved and hypotonic. It gives the cleanest analytical background — nothing extra in the UV trace, nothing extra in the mass spectrum — and is the natural choice for material destined for HPLC or LC-MS characterisation. Once opened it should be treated as single-use.
0.9% sodium chloride is isotonic, which matters when a solution will be diluted into a cell-culture system where osmolarity affects the readout. Plain sodium chloride injection is unpreserved; preserved presentations containing benzyl alcohol exist separately. The higher ionic strength can influence the aggregation behaviour of some sequences, so it is worth a small-scale trial before committing a whole vial.
Dilute acetic acid, typically in the region of 0.1% to 1%, is a solubilisation aid rather than a general diluent. Its role is to get a stubborn basic peptide into solution using the smallest volume that works, after which the solution is made up with water or buffer.
| Use case | Preferred diluent | Why | Watch for |
|---|---|---|---|
| Multi-entry vial sampled over days or weeks | Bacteriostatic water, 0.9% benzyl alcohol | Preservative suppresses organisms introduced at each entry | Chemical stability of the peptide still limits useful life |
| Single-session reconstitution, used immediately | Sterile water for injection | No preservative needed; simplest matrix | Discard the remainder; do not re-enter |
| HPLC or LC-MS characterisation | Sterile water or mobile-phase-compatible buffer | Avoids benzyl alcohol peaks and UV interference | Match the diluent to the starting mobile phase |
| Dilution into a cell-culture assay | 0.9% sodium chloride or assay buffer | Isotonic; osmolarity controlled | Ionic strength can affect aggregation for some sequences |
| Poorly soluble basic peptide | Minimum volume of dilute acetic acid, then dilute | Protonation improves solubility of basic sequences | Keep acid volume small; check final pH |
| Poorly soluble acidic peptide | Minimum volume of dilute ammonia, then dilute | Deprotonation improves solubility of acidic sequences | Avoid prolonged exposure to high pH |
| Long-term storage of prepared solution | None — store the peptide dry | The lyophilised state is the stable state | Aliquot and freeze rather than holding one working vial |
Where the 28-day convention comes from
The 28-day figure attached to opened multi-dose vials is an injection-safety convention, not a peptide-specific stability finding. Centers for Disease Control and Prevention guidance states that “once a multi-dose vial is opened (e.g., needle-punctured) the vial should be dated and discarded within 28 days unless the manufacturer states another date for that opened vial”, and adds that the beyond-use date “should never exceed the manufacturer’s original expiration date”.4
Read carefully, that is a statement about microbiological risk from repeated entry. It says nothing about whether the dissolved molecule is still intact. For research peptides the two limits must be tracked separately, and the chemical limit is frequently the shorter of the two.
The chemical clock usually runs faster
Manning and colleagues catalogue the degradation routes available to a peptide or protein in aqueous solution: deamidation at asparagine and glutamine, oxidation at methionine and cysteine, hydrolysis at labile bonds such as aspartyl-prolyl, disulfide scrambling, and physical aggregation. All of these are markedly slower in the dry lyophilised state than in solution.5
The practical implication is straightforward. If a peptide will not be consumed within a few weeks, the right move is not a better preservative — it is to keep the material lyophilised and reconstitute smaller portions, or to aliquot the reconstituted solution and freeze the aliquots. Our storage guide covers the temperature logic in detail.
Choosing a diluent for laboratory solution preparation
Work through four questions in order and the answer usually falls out.
- How many entries? One session means unpreserved sterile water is sufficient. Multiple entries over days or weeks means bacteriostatic water.
- What is the downstream measurement? Analytical characterisation favours the cleanest possible matrix. Cell-based work favours an isotonic, assay-compatible medium.
- Does the sequence dissolve readily? If the cake does not clear in a few minutes with gentle swirling, the issue is solubility, and a charge-matched co-solvent step is the answer rather than more water.
- How long does the solution need to last? Beyond a couple of weeks, aliquot and freeze rather than relying on any diluent to carry the material.
One habit is worth building. Reconstitute by running the diluent slowly down the inner wall of the vial rather than jetting it directly onto the cake. Peptides are surface-active and shear-sensitive; a directed stream and vigorous shaking both encourage foaming, and foam is an air-water interface where aggregation is favoured. Swirl gently, and give a slow-dissolving cake time rather than force.
Volumes per vial size and the resulting concentration
Diluent volume sets the concentration, and nothing else does. The relationship is simply mass divided by volume: a 5 mg vial made up to 2 mL gives 2.5 mg/mL, which is 250 mcg in every 0.1 mL withdrawn. Table 2 gives the common combinations as a concentration reference for solution preparation.
| Vial mass | 1 mL diluent | 2 mL diluent | 3 mL diluent | 5 mL diluent |
|---|---|---|---|---|
| 2 mg | 2.00 mg/mL · 200 mcg per 0.1 mL | 1.00 mg/mL · 100 mcg per 0.1 mL | 0.67 mg/mL · 67 mcg per 0.1 mL | 0.40 mg/mL · 40 mcg per 0.1 mL |
| 5 mg | 5.00 mg/mL · 500 mcg per 0.1 mL | 2.50 mg/mL · 250 mcg per 0.1 mL | 1.67 mg/mL · 167 mcg per 0.1 mL | 1.00 mg/mL · 100 mcg per 0.1 mL |
| 10 mg | 10.00 mg/mL · 1000 mcg per 0.1 mL | 5.00 mg/mL · 500 mcg per 0.1 mL | 3.33 mg/mL · 333 mcg per 0.1 mL | 2.00 mg/mL · 200 mcg per 0.1 mL |
| 15 mg | 15.00 mg/mL · 1500 mcg per 0.1 mL | 7.50 mg/mL · 750 mcg per 0.1 mL | 5.00 mg/mL · 500 mcg per 0.1 mL | 3.00 mg/mL · 300 mcg per 0.1 mL |
| 50 mg | 50.00 mg/mL · 5000 mcg per 0.1 mL | 25.00 mg/mL · 2500 mcg per 0.1 mL | 16.67 mg/mL · 1667 mcg per 0.1 mL | 10.00 mg/mL · 1000 mcg per 0.1 mL |
Two points about the arithmetic. First, a lyophilised cake occupies a small but real volume, so the final solution volume is marginally greater than the diluent volume added; for milligram quantities in millilitre volumes the error is well under one per cent and is normally ignored. Second, where a certificate reports net peptide content below 100%, the mass on the label is gross lyophilisate and the true peptide mass is lower. Molar calculations should use the net figure.
The reconstitution calculator runs these numbers for any combination, including the corresponding graduation on a U-100 syringe.
Handling, storage and common errors
Unopened bacteriostatic water is stable at controlled room temperature and does not require refrigeration. Once the stopper has been pierced, date the vial. Store it in a way that keeps the label legible, because an undated multi-entry vial is an unusable one — you have no way of knowing which clock it is on.
Wipe the septum with an alcohol swab and let it dry before each entry. A wet swab carries organisms across the surface rather than killing them; the drying time is where the disinfection happens. Use a fresh needle each time. Reusing a needle to save a few pence undoes the entire rationale for buying a preserved diluent.
The four errors that come up most often
- Treating the 28 days as a peptide shelf life. It is a microbiological convention. The chemical stability of the dissolved peptide is a separate, usually shorter, limit.
- Jetting the diluent onto the cake. This foams the solution and drives material to the air-water interface. Run it down the wall instead.
- Shaking to speed dissolution. Gentle swirling and patience work; shaking generates shear and foam. Brief water-bath sonication is a better accelerator where one is available.
- Assuming a preserved diluent extends a reconstituted vial indefinitely. It does not, and a solution that has been held far too long will often look perfectly clear while its purity profile has moved.
Ancillaries in the GenoPept store
Frequently asked questions
What is bacteriostatic water made of?
Bacteriostatic water for injection USP is sterile water for injection with benzyl alcohol added as a bacteriostatic preservative, most commonly at 0.9% (9 mg/mL). The labelled pH is 5.7 with a specification range of 4.5 to 7.0. It contains no buffer, no salt and no other excipient, which is why it is hypotonic and why the label notes that preparations must be made approximately isotonic before use.
How long does bacteriostatic water last after opening?
Injection-safety guidance is to date an opened multi-dose vial and discard it within 28 days of first entry, unless the manufacturer specifies a different period, and never beyond the original expiry date. That figure addresses microbiological risk from repeated entry. It is not a statement about the stability of anything dissolved in the water.
Can I use sterile water instead of bacteriostatic water?
Yes, when the vial will be reconstituted and used in a single session. Sterile water for injection contains no preservative, so it gives the cleanest analytical background and is preferable for HPLC or mass-spectrometry work. It is not suitable for a vial that will be entered repeatedly over days or weeks, because nothing suppresses organisms introduced at each entry.
Does bacteriostatic water sterilise a peptide solution?
No. Benzyl alcohol at 0.9% is bacteriostatic rather than bactericidal — it suppresses the growth of organisms rather than killing an established population. A solution that was contaminated during reconstitution stays contaminated. Aseptic technique at every entry, including a wiped and dried septum and a fresh needle, is still required.
Is bacteriostatic water the same as saline?
No. Bacteriostatic water is preserved but hypotonic and contains no salt. Sodium chloride 0.9% injection is isotonic but, in its plain form, unpreserved. They solve different problems: the preservative addresses repeated entry, while the salt addresses osmolarity in assay systems. Preserved sodium chloride presentations containing benzyl alcohol also exist.
How much bacteriostatic water should I add to a 5 mg vial?
That depends on the concentration you want, since volume alone sets it. Adding 1 mL gives 5 mg/mL, 2 mL gives 2.5 mg/mL and 3 mL gives about 1.67 mg/mL. Larger volumes produce lower concentrations and easier volumetric measurement of small amounts; smaller volumes concentrate the solution. Table 2 in this guide lists the common combinations.
Why does the label say not for use in neonates?
Benzyl alcohol has been associated with serious toxicity in newborn infants, described in the medical literature as the gasping syndrome and reported by Gershanik and colleagues in 1982. Labels for bacteriostatic water carry a prominent warning against neonatal use and direct that preservative-free sterile water be used instead. It is a property of the preservative, not of the water.
Should bacteriostatic water be refrigerated?
Unopened bacteriostatic water is stable at controlled room temperature and does not need refrigeration. Once opened, storage conditions matter less than dating the vial and maintaining aseptic entry. Reconstituted peptide solutions are a different question entirely and are generally kept refrigerated, with longer-term material held frozen in aliquots or, better, left lyophilised.
References
- Bacteriostatic Water for Injection, USP — prescribing information (multiple-dose vial). Pfizer / Hospira. DailyMed label
- Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. New England Journal of Medicine. 1982;307(22):1384–1388. PubMed
- Bachem. Peptide solubility — technical note. bachem.com
- Centers for Disease Control and Prevention. Preventing unsafe injection practices — clinical safety guidance on single-dose and multi-dose vials. cdc.gov
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010;27(4):544–575. PubMed
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nature Reviews Drug Discovery. 2021;20(4):309–325. PubMed
Bacteriostatic water and research peptides from the UK
GenoPept supplies bacteriostatic water containing 0.9% benzyl alcohol alongside lyophilised research peptide vials with per-batch third-party certificates of analysis, dispatched from the UK strictly for laboratory research.